Gene: PPP1R3B
Official Full Name: protein phosphatase 1 regulatory subunit 3Bprovided by HGNC
Gene Summary: This gene encodes the catalytic subunit of the serine/theonine phosphatase, protein phosphatase-1. The encoded protein is expressed in liver and skeletal muscle tissue and may be involved in regulating glycogen synthesis in these tissues. This gene may be a involved in type 2 diabetes and maturity-onset diabetes of the young. Alternate splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14942 | PPP1R3B Knockout cell line (HeLa) | Human | PPP1R3B | 1:3~1:6 | Negative | Online Inquiry |
KO14943 | PPP1R3B Knockout cell line (HCT 116) | Human | PPP1R3B | 1:2~1:4 | Negative | Online Inquiry |
KO14944 | PPP1R3B Knockout cell line (HEK293) | Human | PPP1R3B | 1:3~1:6 | Negative | Online Inquiry |
KO14945 | PPP1R3B Knockout cell line (A549) | Human | PPP1R3B | 1:3~1:4 | Negative | Online Inquiry |
PPP1R3B Gene Knockout Cell Lines are genetically engineered models that have specifically disrupted the PPP1R3B gene, which encodes a regulatory subunit of protein phosphatase 1, playing a crucial role in glycogen metabolism and cellular signaling. This precise gene knockout allows researchers to investigate the functional implications of PPP1R3B deficiency on various cellular processes, including glucose homeostasis and insulin signaling pathways.
The primary mechanism of action for these cell lines involves the complete absence of the PPP1R3B protein, leading to altered phosphorylation states of key substrates within metabolic pathways. As a result, researchers can study how the loss of this protein affects cellular responses to metabolic stress, hormonal regulation, and overall cellular functionality. This information is invaluable, particularly in understanding the pathophysiology of metabolic disorders such as diabetes and obesity.
Scientifically, PPP1R3B Gene Knockout Cell Lines serve as vital tools in both research and clinical settings. They enable the exploration of novel therapeutic targets and contribute to the development of more effective treatments for metabolic diseases. By facilitating high-throughput screening of pharmacological agents or genetic interventions, these cell lines can accelerate the discovery of innovative strategies in personalized medicine.
The advantages of using our PPP1R3B Gene Knockout Cell Lines over alternative models include their precise gene disruption, which allows for a more accurate representation of human disease mechanisms. Additionally, these cell lines are optimized for rapid growth and straightforward application in various experimental setups, ensuring that researchers can obtain reliable and reproducible results.
By choosing our product, researchers and clinicians gain access to high-quality, validated models that enhance their ability to translate basic science into impactful health solutions. Our company has extensive expertise in developing biological research tools, ensuring our customers receive not only superior products but also exceptional support throughout their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.